RE:Keep Things StraightSwine...settle down, Urocidin approval is a slam dunk!
You read the BI article...now most CEO's wouldn't make such bold public statements regarding their risk free cancer trials, particularly when they can't even get their HC submission straight, but most CEOs aren't this successful. Endo also knew it was a slam dunk but they fell asleep at the wheel and Bioniche was able to outsmart them in negotiating it back.
i don't know much, but I do know that regulatory bodies are thrilled, even encouraging, when a CEO says that their yet-to-be -completed submission is a salm dunk. It puts them at ease knowing that the submission they are about to receive will require little to know analysis.
Urocidin is not a matter of if but when...